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Abstract
Objective—To estimate the prevalence and trends of these pelvic floor disorders in U.S. women
from 2005–2010.
Methods—We utilized the National Health and Nutritional Examination Survey (NHANES)
from 2005–2006, 2007–2008, and 2009–2010. A total of 7,924 non-pregnant women (aged 20
years or older) were categorized as having: urinary incontinence – moderate to severe (3 or higher
on a validated urinary incontinence (UI) severity index, range 0–12); fecal incontinence – at least
monthly (solid, liquid, or mucus stool); and pelvic organ prolapse – seeing or feeling a bulge.
Potential risk factors included age, race and ethnicity, parity, education, poverty income ratio,
body mass index (BMI) (<25, 25–29, ≥30 kg/m2), co-morbidity count, and reproductive factors.
Using appropriate sampling weights, weighted chi square analysis and multivariable logistic
regression models with odds ratios (OR) and 95% confidence intervals (95% CI) were reported.
Results—The weighted prevalence rate of one or more pelvic floor disorder was 25.0% (95% CI
23.6, 26.3), including 17.1% (95% CI 15.8, 18.4) of women with moderate-to-severe urinary
incontinence, 9.4% (95% CI 8.6, 10.2) with fecal incontinence, and 2.9% (95% CI 2.5, 3.4) with
prolapse. From 2005 to 2010, no significant differences were found in the prevalence rates of any
individual disorder or for all disorders combined (p>0.05). After adjusting for potential
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confounders, higher BMI, greater parity, and hysterectomy were associated with higher odds of
one or more pelvic floor disorder.
Conclusion—Although rates of pelvic floor disorders did not change from 2005–2010, these
condition remain common with one quarter of adult U.S. women reporting at least one disorder.
INTRODUCTION
Pelvic floor disorders, which include urinary incontinence, fecal incontinence, and pelvic
organ prolapse, are highly prevalent conditions in women, affecting almost 25% of women
in the United States.(1) The landmark study by Nygaard et al. provided the first, national,
population-based estimates of the prevalence of pelvic floor disorders and highlighted the
significant public health burden of these conditions. Because only one year of data was
available, the authors were unable to assess prevalence rate trends over time.
There are several factors that may have impacted trends in the prevalence of pelvic floor
disorders. One important issue is the aging of the U.S population, as these disorders become
more common with increasing age.(1) It is possible that these changing demographics have
resulted in an increase in the prevalence of pelvic floor disorders. In addition, obesity is
associated with these conditions,(1–3) and the obesity epidemic in the U.S. may have
influenced the prevalence of pelvic floor disorders.(4) Furthermore, several studies have
shown that the rates of surgical procedures for urinary incontinence (5–7) and prolapse (8–
10) have increased over time. Given these factors, it is possible that the prevalence of pelvic
floor disorders has changed. Lastly, an evaluation of factors associated with these disorders
in a nationally representative sample will highlight potentially modifiable risk factors, which
we may be able to target for prevention efforts. Thus, our objective was to estimate the
overall prevalence and trends of symptomatic pelvic floor disorders in U.S. women from
2005–2010 and to assess factors associated with these disorders.
MATERIALS AND METHODS
The National Health and Nutritional Examination Survey program consists of cross-
sectional, national health surveys conducted by the National Center for Health Statistics of
the Centers for Disease Control and Prevention (http://www.cdc.gov/nchs/nhanes.htm). This
survey provides estimates of the health status of the U.S. population by selecting a
representative sample of the non-institutionalized population using a complex, stratified,
multi-stage, probability cluster design. The National Health and Nutritional Examination
Survey 2005–2006 oversampled persons aged 60 years or older, and other racial/ethnic
groups (Non-Hispanic Black, Mexican American, and low-income Non-Hispanic White) to
provide more reliable estimates for these groups. In the 2007–2008 and 2009–2010 surveys,
all Hispanic groups were oversampled, not just Mexican Americans. The National Centers
for Health Statistics Ethics Review Board approved the protocol, and all participants
provided written informed consent.(11)
Participants were interviewed in their homes and then underwent standardized physical
examination, including measured height and weight, and further questioning in a mobile
examination center. Trained interviewers asked questions about UI and FI among women
aged 20 years and older in a private mobile examination center interview. Questions on POP
were assessed with questions on the reproductive health questionnaire.
To define each pelvic floor disorder, we used similar methodology to a previous publication
using National Health and Nutritional Examination Survey data from 2005–2006.(1)
(Information regarding the specific questionnaires can be found at: http://www.cdc.gov/
nchs/nhanes/nhanes_questionnaires.htm.) Definitions were utilized to represent more
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bothersome, or symptomatic pelvic floor disorders. We defined urinary incontinence using
the validated 2-item incontinence severity index, which correlates well with incontinence
volume based on 24-hour pad weights and incontinence frequency on bladder diaries.(1) The
incontinence severity index is based on a question about frequency of episodes (<once per
month, a few times a month, a few times a week, or every day and/or night) and a question
about the amount of leakage (drops, splashes, or more). The responses on the two questions
are multiplied to obtain a total severity score that ranges from 1 to 12 (mild or slight
symptoms score 1–2, moderate symptoms 3–6, severe symptoms 7–9, and 10–12 very
severe).16 For this analysis, the categories of severe and very severe symptoms were
combined to define “severe incontinence.” Moderate to severe incontinence corresponds to
at least weekly leakage or monthly leakage of volumes more than just drops.(1) To evaluate
for the occurrence of fecal incontinence, we used the Fecal Incontinence Severity Index,
which asked about the frequency of leakage of gas, mucus, liquid, and/or solid stool leakage
with the following categories: “never,” “two of more times per day,” “once per day,” “two
or more times per week,” “once a week,” to “one to three times per month.”(12) We defined
fecal incontinence as leakage of mucus, liquid, and/or solid stool occurring at least monthly.
Women were asked about prolapse using the previously validated question, “Do you see or
feel a bulge in the vaginal area.”(13) We dichotomized the responses and defined prolapse
as a positive response. From the responses for individual pelvic floor disorders, we created a
combined disorders variable which we refer to as “≥ 1 pelvic floor disorder” that included
the presence of at least one positive response for moderate-to-severe urinary incontinence,
monthly fecal incontinence, or prolapse.
Women self-reported their race and ethnicity, which was then categorized as non-Hispanic
white, non-Hispanic Black, Hispanic (including Mexican American) and other or mixed race
ethnicity. Age was categorized in 10-year increments from 20 years of age to age 79, with
women aged 80 years and older in the same category. Education was categorized as at least
some level of high school education (including General Education Development or
equivalent) or more than high school. The poverty income ratio, an indicator of
socioeconomic status that uses the ratio of income to the family’s poverty threshold set by
the U.S. Census Bureau, was categorized as less than 1 (below the poverty threshold), 1 to 2
(1–2× the poverty threshold), and 2 and more (2× the poverty threshold). From body
measurement data, BMI was calculated as kg/m2 and categorized as less than 25.0
(underweight/normal weight), 25.0 to 29.9 (overweight), and 30.0 or more (obese).
Data on disease types were ascertained through the question “Has a doctor or other health
professional told you that you had [disease]?” In addition to hypertension, disease types also
were examined and categorized as positive by self-report: arthritis, cerebrovascular accident,
chronic lower respiratory tract disease, coronary heart disease, congestive heart failure, liver
disease, thyroid disease, cancer (other than skin), and diabetes mellitus.(14) Chronic lower
respiratory tract disease included self-reported emphysema, chronic bronchitis, or asthma;
coronary heart disease included coronary artery disease, angina, or a myocardial infarction.
Diabetes included participants who also were taking insulin and/or diabetic pills. The
cumulative number of positive responses to these four disease types was divided into four
categories: 0, 1, 2, and 3 or more.
The reproductive health questionnaire reported on parity, type of delivery, and hysterectomy
status. Women responded to the following question on parity: “How many times have you
been pregnant?” with an open response that varied from 0 to 18, with categories created for
0, 1, 2, 3, and 4 or more. Women were asked about the types of deliveries with two separate
questions: “How many vaginal/cesarean deliveries have you had?” Response options were
open-ended and varied from 0–15 for vaginal deliveries and 0–6 for cesarean deliveries. The
variables for type of delivery were then dichotomized as none and at least one or more. A
Wu et al. Page 3













new mode of delivery variable included women who had never been pregnant, women who
had only vaginal deliveries, women who had only cesarean deliveries, and women who had
both. The question, “Have you had a hysterectomy, including a partial hysterectomy, that is,
surgery to remove your uterus or womb?” defined hysterectomy status and response options
were “yes/no.”
The 2005–06, 2007–08, and 2009–2010 survey data for women aged 20 years and older
were combined in order to provide robust sample sizes. Prevalence estimates and 95% CIs
were calculated using STATA 12.0 (STATA Corp. College Station, Texas), which
incorporates the design effect, appropriate sample weights, and the stratification and
clustering of the complex NHANES sample design. The sample weights adjust for unequal
probabilities of selection and nonresponse. The Pearson’s χ 2 test was used to assess the
association between different pelvic floor disorders and demographic and medical
characteristics. Estimates with relative standard errors greater than 30% were identified as
statistically unreliable. Separate multivariable logistic regression models were constructed to
assess factors associated with reporting one or more pelvic floor disorder using variables
from the bivariate analysis that demonstrated statistically significant associations with each
type of pelvic floor disorder. Race and ethnicity was dichotomized as Non-Hispanic White
verses all other racial and ethnic groups in the multivariable analysis. Given collinearity
when the mode of delivery variable (never pregnant, vaginal only, cesarean only, or both)
was included in the multivariable model, mode of delivery was included in additional
models with only exclusive categories (never pregnant and vaginal only or cesarean only or
both). Prevalence ORs and 95% CIs were reported from the multivariable model, using the
appropriate sampling weights, with the level of statistical significance set at p<0.05. In order
to determine if the relationship between hysterectomy and one or more pelvic floor disorder
differed by age, an interaction term was introduced.
RESULTS
From the 14,424 male and female participants (20 years and older), we evaluated data from
8,368 non-pregnant women. Of these women, 7,142 had urinary incontinence data, 7,046
had fecal incontinence data, and 7,071 had prolapse data, with overlap among 7,924 women
with data on the presence of one or more pelvic floor disorder. Women with data on pelvic
floor disorders were not statistically different than the women without pelvic floor disorder
data for age, race and ethnicity, or education level (p>0.05).
Overall, 25.0% (95% CI 23.6, 26.3) of U.S. women reported one or more pelvic floor
disorder. Urinary incontinence was the most common disorder reported, with a combined
prevalence of 17.1% (95% CI 15.8, 18.4). The combined population-based prevalence was
9.4% (95% CI 8.6, 10.2) for fecal incontinence and 2.9% (95% CI 2.5, 3.4) for prolapse. The
population-based prevalence rates for each pelvic floor disorder were not statistically
significant from 2005 – 2010 (Figure 1).
In bivariate analysis (Table 1), increased age by decade was associated with higher
prevalence rates for all pelvic floor disorders. The proportion of women with one or more
pelvic floor disorder dramatically increased from 6.3% (95% CI 5.0, 7.8) in women aged
20–29 to 31.6% (95% CI 28.3, 35.1) for women 50–59 years to 52.7% (95% CI 48.1, 57.2)
for women 80 and older. More non-Hispanic White women had urinary incontinence, fecal
incontinence and one or more pelvic floor disorder than did other racial and ethnic groups.
Mexican-American women reported higher rates of prolapse than other racial/ethnic groups.
Lower educational status (less than a high school education) was associated with higher
prevalence rates for each disorder and one or more pelvic floor disorder. However, a lower
poverty status was not associated with fecal incontinence, but was associated with an
Wu et al. Page 4













increased prevalence of urinary incontinence, prolapse, and one or more pelvic floor
disorder.
Higher BMI, a greater number of cumulative self-reported conditions and diseases, and
hysterectomy were significantly associated with an increased prevalence of each type of
disorder as well as having one or more pelvic floor disorder (Table 1). Increasing parity was
associated with increased prevalence rates of urinary incontinence, fecal incontinence,
prolapse and one or more pelvic floor disorder. Vaginal delivery was associated with higher
rates of POP, FI, UI and having one or more pelvic floor disorder, as compared to cesarean
delivery, never being pregnant, and having both a vaginal delivery and a cesarean. A lower
prevalence of each disorder and having one or more pelvic floor disorder was found for
women who had never been pregnant as compared to the other parity statuses.
After adjusting for age in decades, race, education, poverty status and other reproductive
factors (parity, type of delivery), the odds of having one or more pelvic floor disorder
increased with being overweight (OR 1.3, 95% CI 1.1, 1.6) or obese (OR 1.6, 95% CI 1.3,
2.0) when compared to normal weight women in all models (Table 2). In addition, a prior
hysterectomy, greater parity and having co-morbid diseases were associated with having one
or more pelvic floor disorder (Table 2). An interaction term for age and hysterectomy was
not significant. Mode of delivery (cesarean delivery or vaginal delivery) was not associated
with having one or more pelvic floor disorder. Given collinearity, adjustment for reporting
both vaginal and cesarean deliveries was assessed in a separate multivariable model and was
not significantly associated with having at least 1 pelvic floor disorder (data not shown).
DISCUSSION
These results suggest the prevalence rates of pelvic floor disorders (urinary incontinence,
fecal incontinence and pelvic organ prolapse) have remained stable over the past cycles of
data from the National Health and Nutritional Examination Survey. These conditions
represent a major public health burden, as one quarter of all adult women suffer from at least
one pelvic floor disorder. Although we did not detect a statistically significant difference in
prevalence rates from 2005–2010, it is likely the aging of the population and the obesity
epidemic will lead to increases in the number of women affected by these conditions.
Our study confirms prior findings that the prevalence of pelvic floor disorders significantly
increases with age. Using aggregated survey data from 2005–2010, our estimates were
similar to prior data from 2005–2006 (1) and highlight that 40% of women aged 60–79 and
53% of women 80+ suffer from at least one symptomatic disorder. Although we did not see
an increase in the prevalence rates from 2005–2010, it is likely the prevalence of these
disorders will increase, given the fact that the U.S. population 65 years and older is expected
to double from 40.2 million in 2010 to 88.5 million in 2050.(15) These estimates also
underscore the importance of training providers to care for the multitude of women who are
currently suffering from pelvic floor disorders or who will develop symptoms.
Increasing BMI was associated with a higher prevalence of each pelvic floor disorder. It is
important to evaluate the impact of being overweight and obese on pelvic floor disorders,
given that this is a modifiable risk factor within a population in which the prevalence of
obesity is 35%.(4) Obesity has previously been reported as a risk factor for urinary
incontinence.(16–18) Furthermore, several studies have documented improvements in
urinary incontinence after weight loss and bariatric surgery.(19–23) Higher BMI has also
been associated with prolapse (2, 3); however, weight loss may not improve bothersome
prolapse symptoms.(24) Obesity has also been associated with fecal incontinence, which
affects 16–68% of obese individuals.(25) The prevalence of fecal incontinence has also been
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shown to decrease after weight loss after bariatric surgery (19), further emphasizing the
importance of obesity as a modifiable risk factor. The association of obesity with pelvic
floor disorders highlights the importance of addressing weight loss in obese women and of
screening for these disorders in overweight and obese women.
Hysterectomy and increasing parity were also associated with pelvic floor disorder
symptoms of women in our study. While prior studies have reported an association between
hysterectomy and an increased risk of prolapse (26, 27), the relationship between
hysterectomy and urinary incontinence is less definitive. An older systematic review
reported that a hysterectomy increases the risk of UI (28) while a more recent evidence
review found no association.(29) Our findings regarding parity and the association with
prolapse (2, 27) and urinary incontinence is consistent with those of several prior studies.
(18, 31, 32) Conflicting evidence exists regarding the role of parity and hysterectomy on the
prevalence rate of fecal incontinence among epidemiologic studies and more confirmatory
data are needed. (33–35) However, studies have shown that a third or fourth degree anal
sphincter tear and an instrumented delivery consistently increased the odds of having post-
partum fecal incontinence.(36–38)
The limitations of our study include that causality cannot be ascertained, as the cross-
sectional data were analyzed. Health status and reproductive variables were self-reported;
however, questions from validated instruments were used to assess the presence of pelvic
floor disorders. This national survey assesses only non-institutionalized adults, which may
limit the generalizability of these results to other groups. Additionally, no data were
available regarding whether an operative vaginal delivery (forceps or vacuum) was
performed, degree of obstetrical injuries, history of episiotomy, indication for hysterectomy,
or prior surgery for pelvic floor disorders, all of which are factors that may influence the risk
of these conditions. Finally, the odds ratios of variables associated with pelvic floor disorder
symptoms reflect a modest effect.(39)
Information regarding the national prevalence of urinary incontinence, fecal incontinence,
and pelvic organ prolapse is critical to understanding the public health burden of these
conditions. Furthermore, understanding the prevalence of these disorders provides useful
information regarding the need to address these symptoms proactively with patients as well
as to train healthcare providers to manage these disorders. Our findings underscore the
association between higher BMI and pelvic floor disorders. Thus, more clinical studies are
warranted regarding weight reduction as a potential first-line intervention for the treatment
of pelvic floor disorders among overweight and obese women.
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